Group One Trading, L.P. Vericel Corp Transaction History

Group One Trading, L.P.

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$23.85 - $31.34 $189,178 - $248,588	7,932 Added 3074.42%	8,190 $240,000
Q4 2022 Feb 09, 2023	BUY	$17.65 - $27.37 $4,553 - $7,061	258 New	258 $6,000
Q1 2022 May 12, 2022	SELL	$31.69 - $43.29 $143,143 - $195,540	-4,517 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$35.2 - $52.6 $9,257 - $13,833	263 Added 6.18%	4,517 $178,000
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $151,286 - $195,024	-3,264 Reduced 43.42%	4,254 $208,000
Q2 2021 Aug 10, 2021	BUY	$47.2 - $67.81 $314,352 - $451,614	6,660 Added 776.22%	7,518 $395,000
Q1 2021 May 12, 2021	BUY	$30.93 - $59.48 $26,537 - $51,033	858 New	858 $48,000
Q3 2020 Nov 12, 2020	SELL	$14.68 - $19.12 $98,356 - $128,104	-6,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$8.5 - $15.82 $41,590 - $77,407	4,893 Added 270.78%	6,700 $93,000
Q1 2020 May 13, 2020	BUY	$7.25 - $19.22 $13,100 - $34,730	1,807 New	1,807 $17,000
Q2 2019 Aug 09, 2019	SELL	$15.01 - $18.89 $58,929 - $74,162	-3,926 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$16.23 - $20.29 $63,718 - $79,658	3,926 New	3,926 $69,000
Q3 2018 Nov 08, 2018	SELL	$9.1 - $14.8 $113,449 - $184,511	-12,467 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$9.6 - $14.6 $122,313 - $186,018	-12,741 Reduced 50.54%	12,467 $121,000
Q1 2018 May 11, 2018	BUY	$5.7 - $12.3 $143,685 - $310,058	25,208 New	25,208 $251,000
Q4 2017 Feb 09, 2018	SELL	$3.65 - $5.98 $47,752 - $78,236	-13,083 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$3.0 - $6.0 $29,400 - $58,800	9,800 Added 298.51%	13,083 $79,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,283	3,283 $11,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.